This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
mtaschetta-millane Thu, 07/18/2024 - 10:00 July 18, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced the next generation HeartFlow Plaque Analysis with an interactive experience. This upgraded platform is the only plaque analysis tool fully integrated with FFR CT (when FFR CT is performed), delivering impactful insights to enhance clinical decision-making and enabling personalized patient treatment plans.
Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01047-5 During commercial spaceflight, individuals who might have underlying cardiovascular disease will be exposed to increased gravitational and acceleration (G) forces. In this Review, Morris and colleagues explore the use of computational models to simulate the effects of G forces on human cardiovascular pathophysiology to risk-stratify individuals and help to improve safety in commercial suborbital spaceflight
Circle Cardiovascular Imaging has announced that Erkan Akyuz has been appointed Chief Executive Officer to succeed Circle co-founder and CEO Greg Ogrodnick. Image courtesy: Circle Cardiovascular christine.book Thu, 07/18/2024 - 13:32 July 18, 2024 — Circle Cardiovascular Imaging , a developer of artificial intelligence (AI)-driven cardiovascular imaging solutions, has announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5, 2024.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Le Bonheur Children's Hospital and the University of Tennessee Health Science Center, both based in Memphis, Tenn., have named Bret Mettler, MD, as the new chief of pediatric cardiac surgery and executive co-director of the Le Bonheur and UT Health Science Center Heart Institute.
mtaschetta-millane Thu, 07/18/2024 - 09:19 July 18, 2024 — Elucid , a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support diagnosis and treatment of cardiovascular disease, has initiated site recruitment for its Plaque as a Risk Factor for Evaluation of Vascular Events (PRE-VUE) CT Registry Study.
Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01063-5 Contraction of the heart is driven by cyclical interactions between myosin and actin filaments driven by ATP hydrolysis. In this Review, Irving summarizes the basal cardiac cycle of the healthy human heart at the ventricular, cellular, sarcomeric, and molecular levels and the implications for the development of novel therapies for heart disease.
Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01063-5 Contraction of the heart is driven by cyclical interactions between myosin and actin filaments driven by ATP hydrolysis. In this Review, Irving summarizes the basal cardiac cycle of the healthy human heart at the ventricular, cellular, sarcomeric, and molecular levels and the implications for the development of novel therapies for heart disease.
mtaschetta-millane Thu, 07/18/2024 - 09:05 July 18, 2024 — AliveCor , a global leader in AI-powered cardiology , today announced that the American Medical Association (AMA) has granted new Category III Current Procedural Terminology (CPT) codes that are applicable to the company's Kardia 12L ECG System , which received FDA clearance in June 2024.
How would YOU interpret the rhythm in Figure-1 — if you were sent this tracing without the benefit of any history? Figure-1: How would YOU interpret this rhythm? The "Quick" Answer: My initial thoughts on the rhythm in Figure-1 : The rhythm in Figure-1 is not completely regular. That said — the R-R interval for the first 5 beats looks regular. The R-R interval for the last few beats is shorter than this — but also regular.
The impact of nitric oxide (NO) administered via cardiopulmonary bypass (CPB) on pediatric heart surgery remains controversial. The objective of this study is to conduct a comprehensive systematic review and m.
"UC Irvine receives $50 million gift from Joe Wen and family for cardiology advancements and research, renaming divisions and center in honor of Wen's parents a
What are the effectiveness and safety outcomes associated with apixaban versus rivaroxaban and versus warfarin in patients with cirrhosis and atrial fibrillation (AF)?
Phase 2 data from the ARCHER study shows a protective effect of ANX007 on visual acuity and anatomical measures in the central macula in patients with GA.
What are the national trends in utilization of leadless pacemaker implantation following transcatheter aortic valve replacement (TAVR) and its performance compared with transvenous pacemakers?
Analyze the pattern of lymph node metastasis in Siewert II adenocarcinoma of the esophagogastric junction (AEG) and provide a basis for the principles of surgical access.
"Learn how AirLift Texas emergency air crews are now equipped to transport cardiac patients with intra-aortic balloon pumps, providing faster and safer access t
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies
The Centers for Medicare and Medicaid Services (CMS) released the proposed 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System rule on July 10. CMS proposes a 2.6% increase to OPPS payment rates that reflects a market basket update of 3.0% reduced by a productivity adjustment of 0.4%.
Numerous states have introduced cardiopulmonary resuscitation (CPR) training mandates for high school students and staff to prevent sudden cardiac death (SCD). However, the content and implementation of these mandates vary substantially. Furthermore, a comprehensive and objective assessment of these mandates and their impact is lacking.
In this Q&A interview, Stein Gold discusses new phase 3 findings regarding ruxolitinib cream 1.5% for patients 2 to 11 years old with atopic dermatitis.
Sorana Segal-Maurer, MD, offers clinical insights on treating patients with HIV who have viral mutations, including M184V, highlighting guideline recommendations.
Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Pedro Piccaro de Oliveira, Anibal P. Abelin, Guilherme Pinheiro Machado, Evandro M. Filho, Gustavo N. Araujo, Leandro A. Côrtes, Lucio Padilla, Sebastian Pablo Peralta, Ricardo Santiago, João E.T. de Paula, Antonio Carlos Botelho, Mauro Echavarria-Pinto, Felix Damas de los Santos, Marcelo H.
Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Gani Bajraktari, Ibadete Bytyçi, Genc Abdyli, Pranvera Ibrahimi, Artan Bajraktari, Rona Karahoda, Shpend Elezi, Michael Y.
Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Michael Kachmar, Florina Corpodean, Courtney LaChute, Iryna Popiv, Michael Cook, Denise M Danos, Vance L Albaugh, Denzil L Moraes, WH Wilson Tang, Philip R Schauer
An academic dermatologist discusses the safety profiles of abrocitinib and upadacitinib and provides clinical insights on patient monitoring practices.
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Daniel S. Matasic, Ralph Zeitoun, Gregg C. Fonarow, Alexander C. Razavi, Roger S.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
111 
Let's personalize your content